1. Home
  2. FIVN vs NVCR Comparison

FIVN vs NVCR Comparison

Compare FIVN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five9 Inc.

FIVN

Five9 Inc.

HOLD

Current Price

$20.87

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$18.38

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIVN
NVCR
Founded
2001
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
FIVN
NVCR
Price
$20.87
$18.38
Analyst Decision
Buy
Buy
Analyst Count
18
6
Target Price
$26.06
$28.08
AVG Volume (30 Days)
3.4M
1.7M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
364.71
21.79
EPS
0.21
N/A
Revenue
$1,149,088,000.00
$655,353,000.00
Revenue This Year
$11.39
$7.72
Revenue Next Year
$10.00
$6.74
P/E Ratio
$99.24
N/A
Revenue Growth
10.28
8.28
52 Week Low
$13.29
$9.82
52 Week High
$30.35
$20.05

Technical Indicators

Market Signals
Indicator
FIVN
NVCR
Relative Strength Index (RSI) 60.82 75.89
Support Level $20.49 $12.66
Resistance Level $22.08 N/A
Average True Range (ATR) 1.47 0.99
MACD 0.30 0.48
Stochastic Oscillator 57.14 93.91

Price Performance

Historical Comparison
FIVN
NVCR

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Intelligent CX platform combines core telephony functionality, omnichannel engagement, and modules into a cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, and optimization solutions, as well as artificial intelligence-driven automation solutions that optimize customer service efficiency and manage interaction quality and agent performance.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: